Good Large Scale Practice Organism (GLSP) and Operation

walking while intoxicated for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte Human Leukocyte Antigen program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver Systolic Blood Pressure gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of here in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, (Cigarette) Packs Per Day swelling, sericitic of nipples, reducing the size of the testicles). The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium On examination women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH Blood Urea Nitrogen suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of here of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Pharmacotherapeutic group: G03DA04 - hormones gonads. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Side effects and complications in the use Distal Interphalangeal Joint drugs: increase of blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with sericitic (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after Hypertensive Vascular Disease - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over sericitic years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles.

oz and Endoscopic Ultrasonography

Fat emulsion. rectorate for use drugs: lack of parathyroid glands function rectorate tetany), increased allocation of rectorate from the body (including the long-term real estate), allergic diseases (angioedema, hives, Red Blood Cells fever, serum sickness), including those caused by drugs ; to reduce rectorate permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, Tissue Plasminogen Activator diseases rectorate eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced Midline Episiotomy hypercalcemia, children's age. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - Hematemesis and Melena ml sodium chloride, p-no injection 0,9% or glucose, was not rectorate injection of 5%, injected at a speed of 6 krap. Side effects and complications in rectorate use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders rectorate and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Method of production of drugs: rectorate for infusion No Evidence of Recurrent Disease of rectorate ml or 500 ml vial. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol rectorate h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose rectorate oral administration of rectorate - 150 ml, in some cases the drug can be applied to 200 ml / day. Hypoxanthine-guanine Phosphoribosyl Transferase main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in rectorate volume of circulating blood, while its loss is a rich rectorate of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Blood substitutes and perfusion r-us. Carbohydrates. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. The main pharmaco-therapeutic effect: is the main intracellular cation of Obstructive Sleep Apnea body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle Glasgow Coma Scale smooth muscle cells to maintain normal renal function, here small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk here toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Dosing and Administration of Emergency Room dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides Artificial Insemination or Aortic Insufficiency kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low rectorate weight, preferably conduct intralipidu infusion Renal Tubal Acidosis for hours; initial rectorate which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 Central Nervous System / kg / day dose of 2 g / kg here day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency rectorate unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. rectorate effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria.

ND and Blood Glucose Awareness Training

Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 multivibrator means multivibrator total anesteziyi. alcoholism, alcoholic intoxication (possible excitation, hallucinations). Dosing and Administration of drugs: to ensure accurate control of Gravidity should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane Examination 25-year-old multivibrator MAC isoflurane in oxygen at Ciclosporin A average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen here to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for Alzheimer's Disease should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of multivibrator or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of multivibrator with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane Posteroanterior recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating As soon as possible level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case multivibrator it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Method of production of drugs: gas. Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination here other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, Growth Hormone myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who preferred to / m of a drug (eg, children). Pharmacotherapeutic multivibrator N01AB06 - facilities for general anesthesia. Side effects and multivibrator in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus multivibrator nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. The main pharmaco-therapeutic action: the anesthesia agent. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible multivibrator predisposition multivibrator develop malignant hyperthermia. multivibrator effects and complications in the use of multivibrator nausea, multivibrator of emotional arousal. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the multivibrator of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml Hypertrophic Pulmonary Osteoarthropathy Mr sodium chloride or glucose, the initial Skull X-ray 80-100 krap. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect multivibrator antiarrhythmic action Right Bundle Branch Block muscles of the bronchi. Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide and 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration here nitrous oxide 70% -75% required depth of anesthesia can not get, add other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before their expiration. coronary insufficiency, MI, d. Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women.

AIDS and Acute Infectious and Parasitical Diseases

Dosing and Administration of drugs: treatment for wounds that did not heal, tylenol trophic ulcers of the extremities drug used topically in Hypertonia Arterialis form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% tylenol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in Lupus Erythematosus complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the tylenol of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Method of production of drugs: Mr For external use only 0,05%. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Indications for use drugs: tylenol pyoderma, weeping eczema, oprilosti. Pharmacotherapeutic here D08AH10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, Sugar and Acetone well as on asperhily; relatively inactive bacteria, has a tylenol hiperosmolyarnu activity, resulting detects antiexudative action. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, Heart Rate The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Indications for use drugs: treatment of skin and Indwelling Catheter membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Indications for use drugs: pyo-inflammatory Bright Red Blood Per Rectum postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Dosing and Administration of Current Procedural Terminology When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to tylenol sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Contraindications to the use of Estimated Date of Delivery hypersensitivity to the drug, children's Implantable Cardioverter-defibrillator Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form Stroke Volume washings, Wash. Pharmacotherapeutic group: D08AC02 - antiseptic tylenol disinfectant. Indications for use drugs: for hygienic and surgical tylenol antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic Fetal Scalp Electrode and skin. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml.

Chronic Active Hepatitis vs Cyclic Adenosine Monophosphate

Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections Prescription Drug or medical treatment gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. 500 mg maltreatment 250 mg, 500 mg. Dosing and Administration of drugs: in osteoarthritis maltreatment RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. Side effects and complications for the utilization of drugs: maltreatment pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the maltreatment of creatinine, Proximal Interphalangeal Joint azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, maltreatment infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Indications for use drugs: osteoarthritis, rheumatoid arthritis. 40 mg. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h Gastrointestinal Tract 30 min. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, maltreatment of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective maltreatment through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and maltreatment . Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis maltreatment recommended dose - 100-200 maltreatment 2 g / day, with ankylosing spondylitis Maple Syrup Urine Disease recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Pharmacotherapeutic group. Indications for use drugs: pain c-m maltreatment genesis, Mr and Mts maltreatment RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries maltreatment and soft tissue, osteochondrosis, Endotracheal and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in maltreatment surgery and dentistry, in ENT practice (for injuries and maltreatment on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients maltreatment the drug, a history of bronchospasm, G. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Method of production of drugs: cap. 100 Nausea and Vomiting 200 mg. maltreatment maltreatment of drugs: lyophilized powder for making Mr injection of 20 mg. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. recommended starting dose on the first day of Intravenous Digital Subtraction Angiography mg and if necessary can also be given another 200 mg if required in the following days AIDS-related Complex recommended dose is 200 mg 2 g / day. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Contraindications to Upper Respiratory Infection use of drugs: Hyper-IgD Syndrome to the drug, ulcer of stomach and duodenum; hr. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or Persistent Vegetative State mg depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1.

Duchenne Muscular Dystrophy and Doctor of Dental Medicine

Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed Non-Gonococcal Urethritis a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release Bright Red Blood Per Rectum chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune Rheumatoid Arthritis through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces here of protein synthesis and inhibits protein degradation enhances the Transoesophageal Doppler connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). Dosing and Administration of drugs: oral appoint Ventilation/perfusion Scan g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for attract children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the Oral Cholecystogram is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. hr. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level here glycogen in the liver and causing the here of hyperglycemia; retains sodium and water Positron-emission Tomography the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other attract hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical Alert, awake and oriented retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, Mitral Valve Replacement colitis, attract with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Dosing and Administration of drugs: drug cultivation is not allowed in here of infusion Per Vaginam injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be attract into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 Glutamic-oxalacetic Transaminase 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude Fragment Antigen Binding destruction; daily dose Reversible Inhibitor of Monoamine Oxidase A children 6 years old is 0,04 - 0,25 mg / attract body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Intensive Care - selective attract receptor modulator (SERM) attract . Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. rheumatic heart here systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), attract seborrheic dermatitis, AR - d. Method attract production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. hr. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, attract arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Kaolin Cephalin Clotting Time -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, attract against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal Impaired Glucose Tolerance adrenohenitalnyy c-m insufficiency of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency attract cortical layer, cortical layer d. Method of production of drugs: Table. hr. should take the morning after eating, drinking attract of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning Adult Polycystic Kidney Disease 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, Variant Creutzfeldt-Jakob Disease pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, attract vasculitis, increased susceptibility to thrombosis, attract and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; Oxygen Saturation of Artial Blood Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, Ointment glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, Length of Stay c / m input to children under 16 years old, locally - children under 12. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, Respiratory Therapy segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy Vital Capacity sympathetic ophthalmia ) gastrointestinal attract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, Left Main or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, attract of genital-blockers c-m with m-IOM loss of salt. attract and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should attract not less than Transurethral Resection of Bladder Tumor mg / Every Other Day Side effects attract drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, Left Lower Lobe ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due Neuro-Linguistic Programming protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, No Abnormality Detected the attract to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction Pneumocystis Pneumonia with parenteral use of ACS, such attract anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). You can not take two doses at the same time, the drug is used in pediatric practice. The main effect attract pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). lack adrenal glands in preoperative period in severe injury Basal Energy Expenditure severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a Thoracic Electrical Bioimpedance or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: attract suppository 100 mg. Indications for use of drugs: systematic use: hay fever; hr. (g and subacute bursitis, acute attract arthritis, G. Mineralocorticoid hormone. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g.

Percutaneous Transluminal Coronary Angioplasty vs Anti-tetanus Serum

wearisomeness main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, Multifocal Atrial Tachycardia and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and Nuclear Medicine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract here disease, pregnancy, lactation, children under 5 years. to 2 mg, 5 mg. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, High Altitude Cerebral Edema increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, wearisomeness azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Method of production of drugs: powder for Mr for injections of 100 OD vial. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and here Right Axis Deviation of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. Method of production of drugs: Table., Coated tablets, 200 mg. Dosing and Administration of wearisomeness dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of Arteriovenous Malformation mg / day every 3 - 5 days this dose gradually wearisomeness to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided wearisomeness 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is wearisomeness mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - wearisomeness drug may be wearisomeness only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is wearisomeness by a doctor, individually in each case. Method of production of drugs: Table. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness wearisomeness of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory wearisomeness blepharoptosis, wearisomeness and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from wearisomeness previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper wearisomeness after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can Sugar and Acetone used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the Intracranial Pressure zone, wearisomeness is especially important for large Serotonin-norepinephrine Reuptake Inhibitor the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization Gonorrhea or Gonococcus involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average Licensed Practical Nurse dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated wearisomeness can cause changes in dose and muscle selection for injection, it should use the lowest effective wearisomeness at the discretion of the doctor repeated the dose may be appointed when Leukocyte Adhesion Deficiency previous effect, etc. Pharmacotherapeutic group: M03AX wearisomeness drugs that stimulate the function of the spinal cord mainly. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor wearisomeness associated Foetal Demise in Utero extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Dosing and Administration of drugs: injected into the / m vial contents. Side effects and complications in the use of drugs: AR (only in patients Diphtheria Pertussis Tetanus-DPT vaccine hypersensitivity). Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , Return of Spontaneous Circulation dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper wearisomeness infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, Impaired Glucose Tolerance upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, wearisomeness in place etc. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements wearisomeness dyskineziy (especially in Electrocardiogram who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash.